[Smoking cessation after cancer diagnosis: the importance of extending reimbursement of varenicline]

Epidemiol Prev. 2020 Mar-Jun;44(2-3):110. doi: 10.19191/EP20.2-3.P110.030.

[Article in Italian]

Authors

Roberto Mazza¹, Anna Maria Mancuso¹, Elena Munarini², Chiara Veronese³, Roberto Boffi²

Affiliations

¹ Associazione Salute Donna Onlus, Monza.
² Tobacco Control Unit, Fondazione IRCCS Istituto nazionale dei tumori, Milano.
³ Tobacco Control Unit, Fondazione IRCCS Istituto nazionale dei tumori, Milano; chiara.veronese@istitutotumori.mi.it.

PMID: 32631008
DOI: 10.19191/EP20.2-3.P110.030

No abstract available

Publication types

Letter

MeSH terms

Adult
Health Care Costs
Humans
Neoplasms / diagnosis*
Reimbursement Mechanisms
Smoking Cessation / methods*
Varenicline / therapeutic use*

Substances

Varenicline